Matrix metalloproteinase levels are elevated in inflammatory bowel disease

Area of Science:

• Gastroenterology
• Molecular Biology
• Immunology

Background:

• Inflammatory bowel disease (IBD) encompasses ulcerative colitis (UC) and Crohn's disease (CD).
• Matrix metalloproteinases (MMPs) are enzymes involved in tissue remodeling and inflammation.
• Altered MMP expression is implicated in IBD pathogenesis.

Purpose of the Study:

• To investigate the expression of MMP-1, -2, -3, and -9 in biopsy specimens from IBD patients.
• To compare MMP expression between inflamed and non-inflamed mucosa within the same patient.
• To evaluate differences in MMP expression between IBD patients and healthy controls.

Main Methods:

• Zymography with image analysis was used to quantify proteolytic activity.
• MMP identity was confirmed using specific inhibitors, purified standards, and Western immunoblotting.
• Biopsy specimens were obtained from adult and pediatric patients with UC and CD, as well as control subjects.

Main Results:

• In UC patients, significantly higher MMP activity was observed in inflamed mucosa compared to non-inflamed areas (P = 0.0051).
• Non-inflamed UC mucosa also showed significantly greater MMP activity than control subjects (P < 0.001).
• In CD patients, while differences between inflamed and non-inflamed sites were not significant, protease activity was elevated compared to controls (P < 0.03).
• Matrix metalloproteinase-9 was the most abundant protease in inflamed IBD tissue, likely originating from neutrophils.

Conclusions:

• Matrix metalloproteinase abundance and activation are significantly elevated in the mucosa of patients with UC and CD.
• These findings suggest that MMPs play a crucial role in the inflammatory processes of IBD.
• Inhibitors targeting these proteolytic enzymes may hold therapeutic potential for managing inflammatory bowel disease.